[Current situation and future of gastric cancer screening examinations: from the viewpoint of gastric X-ray screening].
In Japan, screening examinations for gastric cancer have been conducted for 50 years because of the high prevalence of this type of cancer. Gastric X-ray screening examinations have contributed to the detection early gastric cancer. In 2001, Hisamichi et al. reported that X-ray examination is a valid technique in gastric cancer screening. However, they indicated that problems in the uncertainty of accuracy and the risk of radiation exposure at a young age. On the other hand, endoscopic screening examination, pepsinogen-method and H. pylori method are not acceptable because of incident risk. Our future goals are to improve the precision of gastric X-ray examinations in cancer screening nationwide and to advocate for annual gastric screening examinations in higher risk groups. As a result, it is hoped that gastric cancer X-ray screening examinations can contribute to preventive medicine.
Kitagawa
Mayumi
M
Department of Screening Examinations, National Cancer Research Center for Cancer Prevention and Screening.
D000907:Antibodies, Bacterial / Q000097:blood; D015415:Biomarkers / Q000097:blood; D005188:False Negative Reactions; D005773:Gastroscopy; D016480:Helicobacter pylori / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007564:Japan / Q000453:epidemiology; D008403:Mass Screening / Q000639:trends; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000209:etiology; D020116:Pepsinogen A / Q000097:blood; D015995:Prevalence; D011859:Radiography; D018570:Risk Assessment; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging* / Q000453:epidemiology / Q000517:prevention & control*
D000907:Antibodies, Bacterial; D015415:Biomarkers; D007074:Immunoglobulin G; D020116:Pepsinogen A